Genomictree Inc. (228760) — Net Asset Quality Index
Genomictree Inc. (228760) has a Net Asset Quality Index of 95.5% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ₩120.76 Billion minus total liabilities of ₩5.45 Billion yields net assets of ₩115.31 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Read Genomictree Inc. (228760) total liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Genomictree Inc. Net Asset Quality Index Over Time (2020–2025)
This chart shows how Genomictree Inc.'s Net Asset Quality Index has evolved across 6 annual periods from 2020 to 2025. As of December 2025, the index stands at 95.5%, representing net assets of ₩115.31 Billion against total assets of ₩120.76 Billion KRW. For live market cap and overall valuation, see 228760 market cap overview.
Annual Net Asset Quality Index for Genomictree Inc. (2020–2025)
The table below presents the year-by-year Net Asset Quality Index for Genomictree Inc. from 2020 to 2025, covering 6 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check strategic asset allocation of Genomictree Inc. to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (KRW) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 95.5% | ₩115.31 Billion | ₩120.76 Billion | ₩5.45 Billion | ▲ +0.3 pp |
| 2024 | 95.1% | ₩124.32 Billion | ₩130.68 Billion | ₩6.36 Billion | ▲ +1.0 pp |
| 2023 | 94.1% | ₩125.03 Billion | ₩132.84 Billion | ₩7.81 Billion | ▲ +28.4 pp |
| 2022 | 65.7% | ₩107.05 Billion | ₩162.91 Billion | ₩55.86 Billion | ▲ +0.7 pp |
| 2021 | 65.0% | ₩115.10 Billion | ₩177.15 Billion | ₩62.05 Billion | ▼ -15.8 pp |
| 2020 | 80.8% | ₩95.26 Billion | ₩117.90 Billion | ₩22.64 Billion | — |